Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 4Phase 4 3Phase 2/3 3Phase 3 1

Status

Recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 4NETWORK 2INDUSTRY 2NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 3Breast 1

Conditions

Endometrial Neoplasms 3Endometrial Hyperplasia 1Breast Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Medroxyprogesterone Acetate × Clear all
NCT05247268 2026-06-04

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

Fudan University

Phase 2 Recruiting
104 enrolled
Gynecologic

Endometrial Neoplasms

NCT05675787 2024-07-11

Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Peking University People's Hospital

Phase 2 Recruiting
82 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT00577122 2023-10-16

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

Indiana University

Phase 2 Completed
30 enrolled 13 charts
Breast

Breast Neoplasms

NCT03567655 2018-06-26

Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer

Asan Medical Center

Phase 2 Unknown
41 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡